Literature DB >> 30615108

Late-career Physicians Prescribe Longer Courses of Antibiotics.

Cesar I Fernandez-Lazaro1,2, Kevin A Brown1,3, Bradley J Langford1, Nick Daneman1,4,5, Gary Garber1,6, Kevin L Schwartz1,3,7.   

Abstract

BACKGROUND: Antibiotic duration is often longer than necessary. Understanding the reasons for variability in antibiotic duration can inform interventions to reduce prolonged antibiotic use. We aim to describe patterns of interphysician variability in prescribed antibiotic treatment durations and determine physician predictors of prolonged antibiotic duration in the community setting.
METHODS: We performed a retrospective cohort analysis of family physicians in Ontario, Canada, between 1 March 2016 and 28 February 2017, using the Xponent dataset from IQVIA. The primary outcome was proportion of prolonged antibiotic course prescribed, defined as >8 days of therapy. We used multivariable logistic regression models, with generalized estimating equations to account for physician-level clustering to evaluate predictors of prolonged antibiotic courses.
RESULTS: There were 10 616 family physicians included in the study, prescribing 5.6 million antibiotic courses. There was substantial interphysician variability in the proportion of prolonged antibiotic courses (median, 33.3%; interdecile range, 13.5%-60.3%). In the multivariable regression model, later physician career stage, rural location, and a larger pediatric practice were significantly associated with greater use of prolonged courses. Prolonged courses were more likely to be prescribed by late-career physicians (adjusted odds ratio [aOR], 1.48; 95% confidence interval, 1.38-1.58) and mid-career physicians (aOR, 1.25; 1.16-1.34) when compared to early-career physicians.
CONCLUSIONS: We observed substantial variability in prescribed antibiotic duration across family physicians, with durations particularly long among late-career physicians. These findings highlight opportunities for community antimicrobial stewardship interventions to improve antibiotic use by addressing practice differences in later-career physicians. © Crown copyright 2019.

Entities:  

Keywords:  antibiotics; antimicrobial stewardship; outpatient; treatment duration

Mesh:

Substances:

Year:  2019        PMID: 30615108     DOI: 10.1093/cid/ciy1130

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Short-course Antibiotic Therapy-Replacing Constantine Units With "Shorter Is Better".

Authors:  Noah Wald-Dickler; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

2.  Population-based assessment of patient and provider characteristics influencing pediatric outpatient antibiotic use in a high antibiotic-prescribing state.

Authors:  Sophie E Katz; Milner Staub; Youssoufou Ouedraogo; Christopher D Evans; Marion A Kainer; Marie R Griffin; Ritu Banerjee
Journal:  Infect Control Hosp Epidemiol       Date:  2020-01-15       Impact factor: 3.254

3.  Duration of Antibiotic Therapy: Shorter Is Better.

Authors:  Brad Spellberg; Louis B Rice
Journal:  Ann Intern Med       Date:  2019-07-09       Impact factor: 25.391

4.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

5.  Antibiotic Prescribing Choices and Their Comparative C. Difficile Infection Risks: A Longitudinal Case-Cohort Study.

Authors:  Kevin Antoine Brown; Bradley Langford; Kevin L Schwartz; Christina Diong; Gary Garber; Nick Daneman
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

Review 6.  Metrics for evaluating antibiotic use and prescribing in outpatient settings.

Authors:  Valerie Leung; Bradley J Langford; Rita Ha; Kevin L Schwartz
Journal:  JAC Antimicrob Resist       Date:  2021-07-19

7.  Rural-urban differences in antibiotic prescribing for uncomplicated urinary tract infection.

Authors:  Abbye W Clark; Michael J Durkin; Margaret A Olsen; Matthew Keller; Yinjiao Ma; Caroline A O'Neil; Anne M Butler
Journal:  Infect Control Hosp Epidemiol       Date:  2021-02-24       Impact factor: 3.254

8.  Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.

Authors:  Elaine Finn; Fredrik L Andersson; Matthew Madin-Warburton
Journal:  BMC Infect Dis       Date:  2021-05-19       Impact factor: 3.090

Review 9.  Antimicrobial Stewardship Interventions to Combat Antibiotic Resistance: an Update on Targeted Strategies.

Authors:  Kelli A Cole; Kaitlyn R Rivard; Lisa E Dumkow
Journal:  Curr Infect Dis Rep       Date:  2019-08-31       Impact factor: 3.663

10.  Validating a popular outpatient antibiotic database to reliably identify high prescribing physicians for patients 65 years of age and older.

Authors:  Kevin L Schwartz; Cynthia Chen; Bradley J Langford; Kevin A Brown; Nick Daneman; Jennie Johnstone; Julie Hc Wu; Valerie Leung; Gary Garber
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.